TACSTD2 and metastatic malignant neoplasm in the lymph nodes: In Guerra et al., high expression of TROP-2 was found in 40 of 80 patients and was associated with lymph node metastasis (N0: 40% vs. N1–N2: 60%, p = 0.047) [23].